Clinical Trials in Phoenix

Showing 1421-1440 of 16,646 trials

Active Not RecruitingEARLY Phase 1< 1 mile

Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas

NCT06824662

This is an open-label, multi-center Phase 0/1b study that will enroll up to 18 participants with recurrent WHO grade 4 glioblastoma (rGBM) IDH-wildtype (IDH-WT), Arm A, and 12 participants with presumed newly-diagnosed WHO grade 4 glioblastoma (nGBM) IDH-WT, Arm B. The trial will be composed of a Phase 0 component (subdivided into Arms A and B), and an Expansion Phase 1b. Patients with tumors demonstrating a positive pharmacokinetic (PK) response in the Phase 0 component of the study will graduate to an Expansion Phase that combines therapeutic dosing of quisinostat plus standard-of-care fractionated radiotherapy (RT).

Glioblastoma WHO Grade IV

Nader Sanai30 participantsStarted Sep 2025

Phoenix, Arizona, United States

COMPLETEDNA< 1 mile

Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

NCT02985684

Evaluate the safety and efficacy of the GORE® CARDIOFORM ASD Occluder in the percutaneous closure of ostium secundum atrial septal defects (ASDs)

Atrial Septal Defect

W.L.Gore & Associates125 participantsStarted Mar 2017

Phoenix, Arizona, United States • Los Angeles, California, United States • Aurora, Colorado, United States +19 more locations

Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas

Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

Find Trials by Condition in Phoenix

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

ELEVATE High-Risk PCI Pivotal Study

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

An International Observational Study of Adults With Acute Infection

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation